Aztreonam — Drug Intelligence | 10 EU Trials

Filter these 10 trials by condition, phase, country and more.

Open in Search →

10 Registered trials

4 Recruiting

4 Completed trials

8 Sponsors

17 Countries

Phase III

Phase II

Phase IV

Phase III: 5 Phase II: 3 Phase IV: 2

Oversight events:

1 temporary halt across 1 trial

View oversight register →

Indications tested

Abdominal infection 1 Infection 1 Urinary tract infection 1 Diabetic foot infection 1 Bacterial infection 1 Spinal cord injury 1 Antibiotic level therapeutic 1 Sepsis 1

Sponsors using this IMP

Centre Hospitalier Universitaire De Nantes 2 Meiji Seika Pharma Co. Ltd. 2 Assistance Publique Hopitaux De Paris 1 Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla 1 Melinta Therapeutics LLC 1 Micurx Pharmaceuticals Inc. 1 Pfizer Inc. 1 Uppsala Universitet 1

All trials

10 total

ANTIBIOBONTA - Assessment of the interest of a peri-operative antibiotic strategy applied to patients with asymptomatic bacteriuria undergoi… Pending

2024-515107-19-00 Phase III 1 country Centre Hospitalier Universitaire De Lille
Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol Pending

2024-516232-10-00 Phase IV 1 country Centre Hospitalier Universitaire De Nimes
Efficacy and safety of 7 versus 14 days of antibiotic treatment for bacteremia produced by Pseudomonas aeruginosa: a multicenter, randomized… Recruiting

2023-508441-41-00 Phase IV 1 country Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
A Phase 3, Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of Contezolid Acefosamil and Contezolid Compared … Recruiting

2022-500257-16-00 Phase III 15 countries Micurx Pharmaceuticals Inc.
Pivmecillinam as oral step-down treatment for Escherichia coli febrile urinary tract infection versus standard of care; a randomized control… Recruiting

2023-503447-33-00 Phase II 2 countries Uppsala Universitet
A Study of Aztreonam-Avibactam (ATM-AVI) Compared to Best Available Therapy in Pediatric Participants with Serious Gram-Negative Bacterial C… Recruiting

2022-501575-12-00 Phase II 4 countries Pfizer Inc.
COTRIVAP - Efficacy of cotrimoxazole as a de-escalation treatment of Ventilator-Associated Pneumonia in intensive care unit Ended

2023-505108-52-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Study to Assess the Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy in Adults With Complic… Ended

2024-515180-56-00 Phase III 7 countries Meiji Seika Pharma Co. Ltd.
Study to Assess the Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in the Treatment of C… Ended

2024-515463-55-00 Phase III 6 countries Meiji Seika Pharma Co. Ltd.
A Multicenter, Open-Label, Evaluator-Blinded, Randomized Study to Evaluate the Safety and Tolerability of Single-Dose IV Oritavancin for the… Ended

2024-516385-10-00 Phase II 8 countries Melinta Therapeutics LLC

Showing 1–10 of 10 trials

← All drugs A–Z